You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

rel-1017

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDD, Depression Trial (REL-1017)

Available
  • Major Depressive Disorder
  • Depression
  • REL-1017
  • (no location specified)
Aug 17, 2023

MDD, Depression Trial in United States (REL-1017, Placebo)

Recruiting
  • Major Depressive Disorder
  • Depression
  • REL-1017
  • Placebo
  • Culver City, California
  • +5 more
Aug 21, 2023

MDD Trial in United States (REL-1017, Placebo)

Recruiting
  • Major Depressive Disorder
  • REL-1017
  • Placebo
  • Saraland, Alabama
  • +46 more
Jan 18, 2023

MDD Trial in United States (REL-1017, Placebo)

Recruiting
  • Major Depressive Disorder
  • REL-1017
  • Placebo
  • Phoenix, Arizona
  • +57 more
May 9, 2022

MDD Trial in United States (REL-1017, Placebo)

Recruiting
  • Major Depressive Disorder
  • REL-1017
  • Placebo
  • Phoenix, Arizona
  • +52 more
Apr 14, 2022

Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant Trial in United States (REL-1017, Placebo)

Completed
Has Results
  • Depressive Disorder, Major
  • Depressive Disorder, Treatment-Resistant
  • REL-1017
  • Placebo
  • Little Rock, Arkansas
  • +9 more
Mar 16, 2021

MDD Trial in United States (REL-1017)

Recruiting
  • Major Depressive Disorder
  • REL-1017
  • Saraland, Alabama
  • +102 more
Jan 18, 2023

Neuropathic Pain Trial (REL-1017, Placebo)

Completed
  • Neuropathic Pain
  • REL-1017
  • Placebo
  • (no location specified)
Jul 30, 2019

Neuropathic Pain Trial (REL-1017, Placebo)

Completed
  • Neuropathic Pain
  • REL-1017
  • Placebo
  • (no location specified)
Aug 17, 2018